NMN

NMN API

ʻO NMN (β-Nicotinamide Mononucleotide) kahi mea nui NAD⁺ precursor e kākoʻo ana i ka metabolism ikehu cellular, hoʻoponopono DNA, a me ka ʻelemakule olakino. Ua aʻo nui ʻia no kāna kuleana i ka hoʻonui ʻana i nā pae NAD⁺ i nā ʻiʻo e emi iho ana me ka makahiki.

 
Mechanism & Research:

Hoʻololi koke ʻia ʻo NMN i NAD⁺, kahi coenzyme koʻikoʻi i komo i:

ʻO ka hana Mitochondrial a me ka hana ikehu

Hoʻoulu ʻo Sirtuin no nā hopena anti-kahiko

ʻO ke olakino metabolic a me ka ʻike insulin

Neuroprotection a me ke kākoʻo cardiovascular

Hōʻike nā haʻawina preclinical a me nā kānaka mua i ka NMN e hoʻoikaika i ka lōʻihi o ke ola, ka hoʻomanawanui kino, a me ka hana naʻau.

 
Nā hiʻohiʻona API (Gentolex Group):

Maʻemaʻe kiʻekiʻe ≥99%

ʻO ka lāʻau lapaʻau, kūpono no ka waha a i ʻole ka injectable formulations

Hana ʻia ma lalo o nā kūlana GMP-like

He kūpono ka NMN API no ka hoʻohana ʻana i nā mea hoʻohui anti-aging, metabolic therapy, a me ka noiʻi lōʻihi.